Search

everythinglearnresearchcommunity

for

Search:↓

Increasing PBX1 reduces aging and cell death in hair follicle stem cells by boosting SIRT1 and lowering PARP1 activity.

Targeting immune tolerance issues in Alopecia Areata could restore hair growth and maintain remission.

Retinoids can prevent skin cancer in high-risk people but have side effects and require more research on dosing and effectiveness.

Europe needs a clear system to watch over cosmetics for safety and to make sure product claims are true.

Monitoring new epilepsy drugs after they're sold is crucial to find rare and long-term side effects that initial tests might miss.

ERβ has potential in treating prostate cancer and neurodegenerative diseases, but human studies are needed before clinical use.

The document concludes that mesotherapy can be effective for skin and hair treatments, but more research is needed to confirm its safety and effectiveness.

Researchers found specific genes in the part of hair follicles that could help treat hair disorders.

New hair loss treatments may include topical medications, injections, and improved transplant methods.

The symposium concluded that understanding how different species repair tissue and how this changes with age can help advance regenerative medicine.

People with alopecia areata may be more likely to have a certain type of hearing loss.

Eyelash alopecia areata often goes undiagnosed and can lead to complete eyelash regrowth, especially in younger patients.

L-cystine and vitamin B6 at high doses prevented hair loss in mice treated with a chemotherapy drug.

Some treatments can help hair regrowth in alopecia areata, but none offer a cure, and effectiveness varies.

Idiopathic hirsutism causes excessive hair growth in women, can be treated with medication and hair removal, but cannot be fully reversed.

Understanding and manipulating epigenetic changes can potentially lead to human organ regeneration therapies, but more research is needed to improve these methods and minimize risks.

The document concludes that changes in eyelashes and eyelid skin can indicate various local and systemic diseases.

Polyphenols may help treat skin conditions like warts, hair loss, acne, and dark spots, but more research is needed.

Malondialdehyde-modified DNA may trigger an immune response in alopecia areata patients.

THAP1 gene changes do not affect DYT1 dystonia; finasteride may help reduce tics and OCD in Tourette syndrome.

The document concludes that proper diagnosis and evidence-based treatments are crucial for managing hair diseases, and psychological support for patients is important.

Only skin melanocytes, not other types, can color hair in mice.

The document concludes that hormone therapy is essential for treating gender dysphoria, with specific drugs and monitoring protocols recommended for safety and effectiveness.

Hair growth is influenced by hormones and goes through different phases; androgens can both promote and inhibit hair growth depending on the body area.

Active oxygen species might be involved in skin tumor growth, but their exact role is unclear.

New indole-based compounds, particularly cemtirestat, show promise as dual-function drugs for diabetic complications.

Isotretinoin at a low dose for three months does not significantly affect hair growth.

Tofacitinib can temporarily improve hair growth in alopecia universalis, but its effectiveness may decrease over time.

Red light at 627 nm can safely trigger IL-4 release in skin cells, potentially helping treat inflammatory skin conditions.

Cyclosporine A helps hair grow by blocking a process that would otherwise cause hair cells to die.